Oxygen Concentrator Market - Global Forecast To 2030
商品番号 : SMB-86268
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 246 |
| 図表数 | 294 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、酸素濃縮器市場を評価し、種類、技術、流量、用途、エンドユーザー、地域など、様々なセグメントにおける市場規模と将来の成長可能性を予測しています。また、市場をリードする企業の競合分析に加え、各社のプロフィール、製品ラインナップ、最近の動向、主要戦略についても解説しています。
本レポートは、酸素濃縮器市場全体とそのサブセグメントの収益に関する最も正確な推定データを提供することで、市場リーダー企業と新規参入企業を支援します。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、効果的な市場開拓戦略を策定するための洞察を得るのに役立ちます。さらに、本レポートは市場動向を把握し、市場における主要な推進要因、障害、課題、機会に関するデータを提供します。
酸素濃縮器市場は、予測期間中に6.1%のCAGRで成長し、2025年の12億7,000万米ドルから2030年には17億1,000万米ドルに達すると予測されています。
酸素濃縮器市場の成長を促進するには、技術の進歩が不可欠です。最新の機器は、よりコンパクトで軽量、エネルギー効率が高く、ユーザーフレンドリーです。パルス投与技術などの革新的な技術は、特にポータブルモデルにおいて、吸入時にのみ酸素を供給することで酸素を節約し、バッテリー寿命を延ばします。新しい機器は、静音動作、デジタルディスプレイ、アラーム、リモートモニタリング用の接続機能を備え、パルスフローモードと連続フローモードの両方をサポートしています。長持ちするバッテリーを搭載したポータブル濃縮器は、アクティブなユーザーや旅行者に人気があり、FAA（連邦航空局）の航空機用承認を受けているものもあります。IoT統合により、医療提供者とのリアルタイムデータ共有が可能になり、患者のコンプライアンスが向上します。AIアルゴリズムは、呼吸パターンに基づいて酸素供給を最適化します。これらの革新は、利便性と患者の生活の質を向上させ、適用範囲を広げ、採用の増加に伴い市場の成長を促進します。
The oxygen concentrators market is projected to reach USD 1.71 billion by 2030 from USD 1.27 billion in 2025, at a CAGR of 6.1% during the forecast period.
Technological advancements are crucial in driving growth in the oxygen concentrators market. Modern units are more compact, lightweight, energy-efficient, and user-friendly. Innovations like pulse dose technology deliver oxygen only during inhalation to conserve it and extend battery life, especially in portable models. New devices feature silent operation, digital displays, alarms, connectivity for remote monitoring, and support both pulse and continuous flow modes. Portable concentrators with long-lasting batteries are popular among active users and travelers, some FAA-approved for flights. IoT integration enables real-time data sharing with healthcare providers, enhancing patient compliance. AI algorithms optimize oxygen delivery based on respiratory patterns. These innovations improve convenience, patient quality of life, and broaden application scope, fueling market growth as adoption increases.
Based on type, the market is divided into portable and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrator market. The increasing global geriatric population is a key factor driving demand for portable oxygen concentrators (POCs). Older adults are more vulnerable to chronic respiratory conditions such as COPD, pulmonary fibrosis, and hypoxia related to heart failure. Mobility challenges in old age make POCs a practical solution, allowing elderly patients to receive oxygen therapy without being restricted to a stationary device. Being able to carry oxygen support while moving around at home, outdoors, or during travel greatly improves their independence and quality of life. As the aging population continues to grow—especially in developed areas like North America, Europe, and parts of Asia—the demand for compact, dependable, and easy-to-use oxygen devices like POCs steadily increases, strengthening their market dominance.
Based on end users, the OC market has been categorized into home care settings, hospitals and clinics, and ambulatory surgical centers & physician offices. In 2024, home care settings held the largest share in the OC market. The increasing global elderly population is a key factor driving demand in the home care segment of the oxygen concentrators market. Older adults are more vulnerable to chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and age-related decline in lung function. These conditions often require long-term oxygen therapy, which is increasingly managed at home due to its convenience and lower cost. Additionally, elderly patients often face mobility issues, making frequent hospital visits difficult. Home-based oxygen concentrators provide a safe and accessible solution, allowing independence while maintaining continuous respiratory support. Countries like Japan, Germany, Italy, and the US—with rapidly aging populations—are seeing a particularly high adoption of oxygen concentrators in home care settings.
North America is expected to hold the largest share of the OC market during the forecast period. North America, especially the US and Canada, has highly developed healthcare systems equipped with modern diagnostic and therapeutic technologies. The region’s hospitals, clinics, and outpatient centers have widespread access to oxygen delivery equipment, including concentrators. Additionally, structured healthcare policies, integrated insurance networks, and streamlined procurement channels ensure the smooth availability and distribution of these devices. Patients benefit from faster diagnoses and prompt initiation of oxygen therapy. Home care support systems are also advanced, allowing a safe transition from hospital to home with continuous oxygen support. These favorable conditions improve the accessibility and use of oxygen concentrators, especially for chronic patients, and reinforce North America’s leadership position in the global oxygen concentrators market.
A breakdown of the primary participants (supply-side) for the oxygen concentrators market referred to in this report is provided below:
- By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
- By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
- By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%
Major players in the oxygen concentrators market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), Caire, Inc. (US), and Drive DeVilbiss Healthcare (US).
Research Coverage
The report assesses the oxygen concentrators market and estimates its size and future growth potential across various segments, including type, technology, flow rate, application, end user, and region. It also provides a competitive analysis of the leading companies in the market, along with their profiles, product offerings, recent developments, and key strategies.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing data on the closest estimates of revenue for the overall oxygen concentrators market and its subsegments. It will aid stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp market trends and offers data on key drivers, obstacles, challenges, and opportunities within the market.
This report provides insights into the following points:
Analysis of key drivers (rising prevalence of respiratory diseases, growing geriatric population, increasing demand for home healthcare, government initiatives and reimbursement support, technological advancements), restraints (high cost of advanced oxygen concentrators, product recalls or malfunctions), opportunities (integration of digital health features, development of solar-powered or battery-efficient models) and challenges (lack of awareness and diagnosis, competition from low-cost alternatives)
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global OC market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, technology, flowrate, application, end user, and region
- Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global OC market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global OC market
Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS AND EXCLUSIONS 25
1.3 STUDY SCOPE 26
1.3.1 SEGMENTS COVERED 26
1.4 YEARS CONSIDERED 27
1.5 CURRENCY USED 27
1.6 STAKEHOLDERS 28
1.7 LIMITATIONS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 33
2.2 MARKET SIZE ESTIMATION 35
2.3 DATA TRIANGULATION 41
2.4 MARKET SHARE ESTIMATION 42
2.5 STUDY ASSUMPTIONS 42
2.6 METHODOLOGY-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 48
4.1 OXYGEN CONCENTRATORS MARKET OVERVIEW 48
4.2 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY AND COUNTRY 49
4.3 OXYGEN CONCENTRATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
4.4 OXYGEN CONCENTRATORS MARKET, REGIONAL MIX 50
4.5 OXYGEN CONCENTRATORS MARKET: EMERGING VS. DEVELOPED MARKETS 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Growing prevalence of chronic respiratory diseases 53
5.2.1.2 Preference for home-based oxygen therapy 54
5.2.1.3 Technological advancements in portable oxygen concentrators 54
5.2.2 RESTRAINTS 55
5.2.2.1 High initial cost and limited reimbursement in some markets 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Expansion in emerging markets 55
5.2.3.2 Integration with remote monitoring and telehealth 56
5.2.3.3 Institutional demand and tender-based opportunities 56
5.2.4 CHALLENGES 57
5.2.4.1 Operational limitations in remote and power-constrained areas 57
5.2.4.2 Quality variability and regulatory compliance challenges 57
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58
5.4 PRICING ANALYSIS 59
5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE 59
5.4.2 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION 60
5.5 VALUE CHAIN ANALYSIS 61
5.6 SUPPLY CHAIN ANALYSIS 62
5.7 ECOSYSTEM ANALYSIS 64
5.8 INVESTMENT & FUNDING SCENARIO 65
5.9 TECHNOLOGY ANALYSIS 67
5.9.1 KEY TECHNOLOGIES 67
5.9.1.1 Pressure swing adsorption (PSA) technology 67
5.9.1.2 Pulse-dose vs. continuous flow delivery 67
5.9.2 COMPLEMENTARY TECHNOLOGIES 68
5.9.2.1 Remote patient monitoring (RPM) integration 68
5.9.2.2 Battery and power management systems 68
5.9.3 ADJACENT TECHNOLOGIES 68
5.9.3.1 PSA oxygen plants 68
5.9.3.2 Oxygen cylinders as backup systems 68
5.10 INDUSTRY TRENDS 69
5.10.1 RISING DEMAND FOR HOME-BASED OXYGEN THERAPY 69
5.10.2 INTEGRATION WITH TELEHEALTH AND REMOTE MONITORING 69
5.10.3 SHIFT TOWARD PORTABLE AND WEARABLE TECHNOLOGIES 69
5.10.4 CONSOLIDATION AND COMPETITIVE LANDSCAPE EVOLUTION 69
5.11 PATENT ANALYSIS 70
5.12 TRADE ANALYSIS 71
5.12.1 IMPORT DATA (HS CODE 901920) 71
5.12.2 EXPORT DATA (HS CODE 901920) 72
5.13 KEY CONFERENCES & EVENTS, 2025–2026 73
5.14 CASE STUDY ANALYSIS 74
5.14.1 DEPLOYMENT OF PORTABLE OXYGEN CONCENTRATORS IN RURAL INDIA 74
5.14.2 INOGEN’S DIRECT-TO-CONSUMER EXPANSION IN US 74
5.14.3 BELLUSCURA’S STRATEGIC PARTNERSHIP WITH CHINESE OEM 74
5.15 REGULATORY ANALYSIS 75
5.16 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.16.1 REGULATORY LANDSCAPE 76
5.16.1.1 North America 76
5.16.1.1.1 US 77
5.16.1.1.2 Canada 77
5.16.1.2 Europe 77
5.16.1.2.1 Germany 77
5.16.1.2.2 France 77
5.16.1.2.3 UK 78
5.16.1.3 Asia Pacific 78
5.16.1.3.1 China 78
5.16.1.3.2 Japan 79
5.16.1.3.3 India 79
5.16.1.4 Latin America 79
5.16.1.4.1 Brazil 79
5.16.1.4.2 Mexico 80
5.16.1.5 Middle East & Africa 80
5.16.1.5.1 South Africa 80
5.16.1.5.2 GCC Countries 80
5.17 PORTER’S FIVE FORCES ANALYSIS 81
5.17.1 THREAT OF NEW ENTRANTS 82
5.17.2 THREAT OF SUBSTITUTES 82
5.17.3 BARGAINING POWER OF SUPPLIERS 82
5.17.4 BARGAINING POWER OF BUYERS 82
5.17.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.18 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.18.2 BUYING CRITERIA 84
5.19 UNMET NEEDS/END-USER EXPECTATIONS 85
5.20 IMPACT OF 2025 US TARIFF ON OXYGEN CONCENTRATORS MARKET 85
5.20.1 KEY TARIFF RATES 86
5.20.2 PRICE IMPACT ANALYSIS 87
5.20.3 KEY IMPACT ON COUNTRY/REGION 87
5.20.3.1 US 87
5.20.3.2 Europe 87
5.20.3.3 Asia Pacific 88
5.20.4 IMPACT ON END-USER INDUSTRIES 88
5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON OXYGEN CONCENTRATORS MARKET 88
5.22 ADJACENT MARKET ANALYSIS 89
6 OXYGEN CONCENTRATORS MARKET, BY TYPE 90
6.1 INTRODUCTION 91
6.2 PORTABLE OXYGEN CONCENTRATORS 91
6.3 STATIONARY OXYGEN CONCENTRATORS 93
7 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY 95
7.1 INTRODUCTION 96
7.2 CONTINUOUS FLOW 96
7.3 PULSE FLOW 97
8 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE 99
8.1 INTRODUCTION 100
8.2 0–5 L/MIN FLOWRATE 100
8.3 5–10 L/MIN FLOWRATE 101
8.4 ABOVE 10 L/MIN FLOWRATE 102
9 OXYGEN CONCENTRATORS MARKET, BY APPLICATION 104
9.1 INTRODUCTION 105
9.2 COPD 105
9.3 ASTHMA 106
9.4 RESPIRATORY DISTRESS 107
9.5 OTHER APPLICATIONS 108
10 OXYGEN CONCENTRATORS MARKET, BY END USER 110
10.1 INTRODUCTION 111
10.2 HOME CARE SETTINGS 111
10.3 HOSPITALS & CLINICS 112
10.4 AMBULATORY SURGICAL CENTERS & PHYSICIANS’ OFFICES 113
11 OXYGEN CONCENTRATORS MARKET, BY REGION 115
11.1 INTRODUCTION 116
11.2 NORTH AMERICA 116
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 117
11.2.2 US 120
11.2.2.1 Medicare coverage, COPD prevalence, and connected POCs to catalyze sustained market expansion through 2030 120
11.2.3 CANADA 122
11.2.3.1 Provincial funding, COPD burden, and connected POCs to accelerate home oxygen concentrator adoption trajectory 122
11.3 EUROPE 124
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 125
11.3.2 GERMANY 127
11.3.2.1 Strong payer coverage and clinical guidelines to drive predictable replacement cycles in Germany’s market 127
11.3.3 FRANCE 130
11.3.3.1 Hospital‑to‑home shift and connected devices sustain resilient replacement cycles in France’s oxygen concentrators market 130
11.3.4 UK 132
11.3.4.1 Aging population and funded home oxygen programs to underpin steady expansion 132
11.3.5 ITALY 134
11.3.5.1 Regional tenders, SSN homecare funding, and COPD burden to support steady growth in Italy’s market 134
11.3.6 SPAIN 137
11.3.6.1 Driving home-based healthcare with portable oxygen concentrator growth 137
11.3.7 REST OF EUROPE 139
11.4 ASIA PACIFIC 141
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 142
11.4.2 JAPAN 145
11.4.2.1 Stable funding and service‑led home care models to support steady growth 145
11.4.3 CHINA 148
11.4.3.1 Policy momentum and robust manufacturing ecosystem to drive resilient replacement cycles 148
11.4.4 INDIA 150
11.4.4.1 Building resilient healthcare infrastructure with rising oxygen concentrator demand 150
11.4.5 SOUTH KOREA 152
11.4.5.1 Hospital‑to‑home shift and connected POCs to propel South Korea’s portable and stationary oxygen concentrator demand growth 152
11.4.6 AUSTRALIA 155
11.4.6.1 Policy support, service networks, and digital monitoring to drive steady expansion of Australia’s market through 2030 155
11.4.7 REST OF ASIA PACIFIC 157
11.5 LATIN AMERICA 159
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 160
11.5.2 BRAZIL 162
11.5.2.1 Public procurement, ANVISA registration, and service networks to drive predictable replacement cycles in Brazil’s oxygen therapy landscape 162
11.5.3 MEXICO 164
11.5.3.1 Strengthening respiratory care access through expanding oxygen concentrator adoption 164
11.5.4 REST OF LATIN AMERICA 167
11.6 MIDDLE EAST & AFRICA 169
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 170
11.7 GCC COUNTRIES 172
11.7.1 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 172
12 COMPETITIVE LANDSCAPE 175
12.1 OVERVIEW 175
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 175
12.3 REVENUE ANALYSIS 179
12.4 MARKET SHARE ANALYSIS 180
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 182
12.5.1 STARS 182
12.5.2 EMERGING LEADERS 182
12.5.3 PERVASIVE PLAYERS 182
12.5.4 PARTICIPANTS 182
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 184
12.5.5.1 Company footprint 184
12.5.5.2 Regional footprint 185
12.5.5.3 Type footprint 186
12.5.5.4 Application footprint 187
12.5.5.5 End User footprint 188
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 189
12.6.1 PROGRESSIVE COMPANIES 189
12.6.2 RESPONSIVE COMPANIES 189
12.6.3 DYNAMIC COMPANIES 189
12.6.4 STARTING BLOCKS 189
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 191
12.6.5.1 Detailed list of key startups/SMEs 191
12.6.5.2 Competitive benchmarking of startups/SMEs 192
12.7 COMPANY VALUATION AND FINANCIAL METRICS 193
12.7.1 FINANCIAL METRICS 193
12.7.2 COMPANY VALUATION 193
12.8 BRAND/PRODUCT COMPARISON 194
12.9 COMPETITIVE SCENARIO 195
12.9.1 PRODUCT LAUNCHES 195
12.9.2 DEALS 196
12.9.3 EXPANSIONS 197
13 COMPANY PROFILES 198
13.1 KEY PLAYERS 198
13.1.1 KONINKLIJKE PHILIPS N.V. 198
13.1.1.1 Business overview 198
13.1.1.2 Products offered 199
13.1.1.3 MnM view 200
13.1.1.3.1 Right to win 200
13.1.1.3.2 Strategic choices 200
13.1.1.3.3 Weaknesses and competitive threats 200
13.1.2 INOGEN, INC. 201
13.1.2.1 Business overview 201
13.1.2.2 Products offered 202
13.1.2.3 Recent developments 203
13.1.2.3.1 Product launches & approvals 203
13.1.2.3.2 Deals 203
13.1.2.4 MnM view 204
13.1.2.4.1 Right to win 204
13.1.2.4.2 Strategic choices 204
13.1.2.4.3 Weaknesses and competitive threats 204
13.1.3 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. 205
13.1.3.1 Business overview 205
13.1.3.2 Products offered 205
13.1.3.3 Recent developments 206
13.1.3.3.1 Deals 206
13.1.3.4 MnM view 206
13.1.3.4.1 Right to win 206
13.1.3.4.2 Strategic choices 206
13.1.3.4.3 Weaknesses and competitive threats 207
13.1.4 CAIRE INC. 208
13.1.4.1 Business overview 208
13.1.4.2 Products offered 208
13.1.4.3 Recent developments 209
13.1.4.3.1 Product launches & approvals 209
13.1.4.3.2 Deals 209
13.1.4.3.3 Expansions 209
13.1.4.4 MnM view 210
13.1.4.4.1 Right to win 210
13.1.4.4.2 Strategic choices 210
13.1.4.4.3 Weaknesses and competitive threats 210
13.1.5 DRIVE DEVILBISS HEALTHCARE 211
13.1.5.1 Business overview 211
13.1.5.2 Products offered 211
13.1.5.3 Recent developments 212
13.1.5.3.1 Product launches & approvals 212
13.1.5.4 MnM view 212
13.1.5.4.1 Right to win 212
13.1.5.4.2 Strategic choices 212
13.1.5.4.3 Weaknesses and competitive threats 212
13.1.6 TEIJIN LIMITED 213
13.1.6.1 Business overview 213
13.1.6.2 Products offered 214
13.1.7 DAIKIN INDUSTRIES, LTD. 215
13.1.7.1 Business overview 215
13.1.7.2 Products offered 216
13.1.8 ESAB CORPORATION (GCE GROUP) 217
13.1.8.1 Business overview 217
13.1.8.2 Products offered 218
13.1.9 REACT HEALTH 219
13.1.9.1 Business overview 219
13.1.9.2 Products offered 219
13.1.9.3 Recent developments 219
13.1.9.3.1 Deals 219
13.1.10 PRECISION MEDICAL, INC. 220
13.1.10.1 Business overview 220
13.1.10.2 Products offered 220
13.1.11 NIDEK MEDICAL PRODUCTS, INC. 221
13.1.11.1 Business overview 221
13.1.11.2 Products offered 221
13.1.12 O2 CONCEPTS, LLC 222
13.1.12.1 Business overview 222
13.1.12.2 Products offered 222
13.1.12.3 Recent developments 223
13.1.12.3.1 Product launches & approvals 223
13.1.12.3.2 Deals 223
13.1.13 BPL MEDICAL TECHNOLOGIES 224
13.1.13.1 Business overview 224
13.1.13.2 Products offered 224
13.1.14 BESCO 225
13.1.14.1 Business overview 225
13.1.14.2 Products offered 225
13.1.15 OXUS 226
13.1.15.1 Business overview 226
13.1.15.2 Products offered 226
13.2 OTHER COMPANIES 227
13.2.1 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD 227
13.2.2 LONGFIAN SCITECH CO., LTD. 228
13.2.3 SHENYANG CANTA MEDICAL TECH. CO., LTD. 229
13.2.4 BELLUSCURA 230
13.2.5 HOYO SCITECH CO., LTD. 231
13.2.6 HACENOR SOLUTIONS 232
13.2.7 XNUO INTERNATIONAL GROUP (USA) HOLDINGS 232
13.2.8 OXYMED 233
13.2.9 KALSTEIN 234
13.2.10 ESS PEE ENTERPRISES 235
14 APPENDIX 236
14.1 DISCUSSION GUIDE 236
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 242
14.3 CUSTOMIZATION OPTIONS 244
14.4 RELATED REPORTS 244
14.5 AUTHOR DETAILS 245
LIST OF TABLES
TABLE 1 USD STANDARD CURRENCY CONVERSION RATES, 2020–2024 27
TABLE 2 RISK ASSESSMENT: OXYGEN CONCENTRATORS 43
TABLE 3 OXYGEN CONCENTRATORS MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS 53
TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD) 59
TABLE 5 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS,
BY REGION, 2022–2024 (USD) 60
TABLE 6 OXYGEN CONCENTRATORS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64
TABLE 7 IMPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 71
TABLE 8 EXPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 72
TABLE 9 OXYGEN CONCENTRATORS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 73
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 75
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 14 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 15 OXYGEN CONCENTRATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 82
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS 83
TABLE 17 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84
TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 86
TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OXYGEN CONCENTRATORS 87
TABLE 20 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 91
TABLE 21 EXAMPLES OF PORTABLE OXYGEN CONCENTRATORS (POC) 91
TABLE 22 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 92
TABLE 23 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2023–2030 (UNITS) 92
TABLE 24 EXAMPLES OF STATIONARY OXYGEN CONCENTRATORS (POC) 93
TABLE 25 STATIONARY OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 26 STATIONARY OXYGEN CONCENTRATORS MARKET, BY REGION,
2023–2030 (UNITS) 94
TABLE 27 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 96
TABLE 28 CONTINUOUS-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 97
TABLE 29 PULSE-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 30 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 100
TABLE 31 0–5 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 32 5–10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 33 ABOVE 10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 34 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 105
TABLE 35 OXYGEN CONCENTRATORS MARKET FOR COPD, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 36 OXYGEN CONCENTRATORS MARKET FOR ASTHMA, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 37 OXYGEN CONCENTRATORS MARKET FOR RESPIRATORY DISTRESS,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 38 OXYGEN CONCENTRATORS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 39 OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 111
TABLE 40 OXYGEN CONCENTRATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 41 OXYGEN CONCENTRATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 42 OXYGEN CONCENTRATORS MARKET FOR AMBULATORY SURGICAL CENTERS & PHYSICIANS’ OFFICES, BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 43 OXYGEN CONCENTRATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 44 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 45 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 118
TABLE 46 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 118
TABLE 47 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 119
TABLE 48 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 49 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 119
TABLE 50 US: MACROECONOMIC INDICATORS 120
TABLE 51 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120
TABLE 52 US: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 121
TABLE 53 US: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 121
TABLE 54 US: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 121
TABLE 55 US: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 122
TABLE 56 CANADA: MACROECONOMIC INDICATORS 122
TABLE 57 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 123
TABLE 58 CANADA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 123
TABLE 59 CANADA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 123
TABLE 60 CANADA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 124
TABLE 61 CANADA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 124
TABLE 62 EUROPE: OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 63 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 126
TABLE 64 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 126
TABLE 65 EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 126
TABLE 66 EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 127
TABLE 67 EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 127
TABLE 68 GERMANY: MACROECONOMIC INDICATORS 128
TABLE 69 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 128
TABLE 70 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 128
TABLE 71 GERMANY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 129
TABLE 72 GERMANY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 73 GERMANY: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 129
TABLE 74 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 75 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 130
TABLE 76 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 131
TABLE 77 FRANCE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 131
TABLE 78 FRANCE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 131
TABLE 79 FRANCE: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 132
TABLE 80 UK: MACROECONOMIC INDICATORS 133
TABLE 81 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 82 UK: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 133
TABLE 83 UK: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 133
TABLE 84 UK: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 134
TABLE 85 UK: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 134
TABLE 86 ITALY: MACROECONOMIC INDICATORS 135
TABLE 87 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135
TABLE 88 ITALY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 135
TABLE 89 ITALY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 136
TABLE 90 ITALY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 136
TABLE 91 ITALY: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 136
TABLE 92 SPAIN: MACROECONOMIC INDICATORS 137
TABLE 93 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137
TABLE 94 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 138
TABLE 95 SPAIN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 138
TABLE 96 SPAIN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 138
TABLE 97 SPAIN: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 139
TABLE 98 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 140
TABLE 99 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 140
TABLE 100 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 140
TABLE 101 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 141
TABLE 102 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 141
TABLE 103 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 104 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 144
TABLE 105 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 144
TABLE 106 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 144
TABLE 107 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 145
TABLE 108 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 145
TABLE 109 JAPAN: MACROECONOMIC INDICATORS 146
TABLE 110 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 111 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 146
TABLE 112 JAPAN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 147
TABLE 113 JAPAN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 147
TABLE 114 JAPAN: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 147
TABLE 115 CHINA: MACROECONOMIC INDICATORS 148
TABLE 116 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 117 CHINA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 149
TABLE 118 CHINA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 149
TABLE 119 CHINA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 149
TABLE 120 CHINA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 121 INDIA: MACROECONOMIC INDICATORS 150
TABLE 122 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151
TABLE 123 INDIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 151
TABLE 124 INDIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 151
TABLE 125 INDIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 152
TABLE 126 INDIA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS 153
TABLE 128 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 129 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 153
TABLE 130 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 154
TABLE 131 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 154
TABLE 132 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 133 AUSTRALIA: MACROECONOMIC INDICATORS 155
TABLE 134 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 155
TABLE 135 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 156
TABLE 136 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 156
TABLE 137 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 156
TABLE 138 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 139 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 140 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 158
TABLE 141 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 158
TABLE 142 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159
TABLE 143 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 159
TABLE 144 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 145 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 146 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 161
TABLE 147 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 161
TABLE 148 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 161
TABLE 149 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 162
TABLE 150 BRAZIL: MACROECONOMIC INDICATORS 163
TABLE 151 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 152 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 163
TABLE 153 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 163
TABLE 154 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 164
TABLE 155 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 164
TABLE 156 MEXICO: MACROECONOMIC INDICATORS 165
TABLE 157 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 158 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 165
TABLE 159 MEXICO: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 166
TABLE 160 MEXICO: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 166
TABLE 161 MEXICO: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 166
TABLE 162 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 163 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 168
TABLE 164 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 168
TABLE 165 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168
TABLE 166 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 169
TABLE 167 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 168 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 170
TABLE 169 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 171
TABLE 170 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171
TABLE 171 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 171
TABLE 172 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 173 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 173
TABLE 174 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2023–2030 (USD MILLION) 173
TABLE 175 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 174
TABLE 176 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 177 KEY DEVELOPMENTS IN OXYGEN CONCENTRATORS MARKET,
JANUARY 2021–JULY 2025 176
TABLE 178 OXYGEN CONCENTRATORS MARKET: DEGREE OF COMPETITION 180
TABLE 179 OXYGEN CONCENTRATORS MARKET: REGIONAL FOOTPRINT, 2024 185
TABLE 180 OXYGEN CONCENTRATORS MARKET: TYPE FOOTPRINT, 2024 186
TABLE 181 OXYGEN CONCENTRATORS MARKET: APPLICATION FOOTPRINT, 2024 187
TABLE 182 OXYGEN CONCENTRATORS MARKET: END USER FOOTPRINT, 2024 188
TABLE 183 OXYGEN CONCENTRATORS MARKET: DETAILED LIST OF KEY
STARTUPS/SMES, 2024 191
TABLE 184 OXYGEN CONCENTRATORS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 192
TABLE 185 OXYGEN CONCENTRATORS MARKET: PRODUCT LAUNCHES,
JANUARY 2021–JULY 2025 195
TABLE 186 OXYGEN CONCENTRATORS MARKET: DEALS, JANUARY 2021–JULY 2025 196
TABLE 187 OXYGEN CONCENTRATORS MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 197
TABLE 188 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 198
TABLE 189 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 199
TABLE 190 INOGEN, INC.: COMPANY OVERVIEW 201
TABLE 191 INOGEN, INC.: PRODUCTS OFFERED 202
TABLE 192 INOGEN, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2025 203
TABLE 193 INOGEN INC.: DEALS 203
TABLE 194 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: COMPANY OVERVIEW 205
TABLE 195 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: PRODUCTS OFFERED 205
TABLE 196 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD..: DEALS 206
TABLE 197 CAIRE INC.: COMPANY OVERVIEW 208
TABLE 198 CAIRE INC.: PRODUCTS OFFERED 208
TABLE 199 CAIRE INC.: PRODUCT LAUNCHES & APPROVALS 209
TABLE 200 CAIRE INC.: DEALS 209
TABLE 201 CAIRE INC.: EXPANSIONS 209
TABLE 202 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW 211
TABLE 203 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED 211
TABLE 204 DRIVE DEVILBISS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 212
TABLE 205 TEIJIN LIMITED: COMPANY OVERVIEW 213
TABLE 206 TEIJIN LIMITED: PRODUCTS OFFERED 214
TABLE 207 DAIKIN INDUSTRIES, LTD.: COMPANY OVERVIEW 215
TABLE 208 DAIKIN INDUSTRIES, LTD.: PRODUCTS OFFERED 216
TABLE 209 ESAB CORPORATION (GCE GROUP): COMPANY OVERVIEW 217
TABLE 210 ESAB CORPORATION (GCE GROUP): PRODUCTS OFFERED 218
TABLE 211 REACT HEALTH: COMPANY OVERVIEW 219
TABLE 212 REACT HEALTH: PRODUCTS OFFERED 219
TABLE 213 REACT HEALTH.: DEALS, JANUARY 2021–JULY 2025 219
TABLE 214 PRECISION MEDICAL, INC.: COMPANY OVERVIEW 220
TABLE 215 PRECISION MEDICAL, INC.: PRODUCTS OFFERED 220
TABLE 216 NIDEK MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW 221
TABLE 217 NIDEK MEDICAL PRODUCTS, INC.: PRODUCTS OFFERED 221
TABLE 218 O2 CONCEPTS, LLC: COMPANY OVERVIEW 222
TABLE 219 O2 CONCEPTS, LLC: PRODUCTS OFFERED 222
TABLE 220 O2 CONCEPTS, LLC: PRODUCT LAUNCHES & APPROVALS 223
TABLE 221 O2 CONCEPTS, LLC: DEALS 223
TABLE 222 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 224
TABLE 223 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 224
TABLE 224 BESCO: COMPANY OVERVIEW 225
TABLE 225 BESCO: PRODUCTS OFFERED 225
TABLE 226 OXUS: COMPANY OVERVIEW 226
TABLE 227 OXUS: PRODUCTS OFFERED 226
TABLE 228 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD: COMPANY OVERVIEW 227
TABLE 229 LONGFIAN SCITECH CO., LTD.: COMPANY OVERVIEW 228
TABLE 230 SHENYANG CANTA MEDICAL TECH. CO., LTD.: COMPANY OVERVIEW 229
TABLE 231 BELLUSCURA: COMPANY OVERVIEW 230
TABLE 232 HOYO SCITECH CO., LTD.: COMPANY OVERVIEW 231
TABLE 233 HACENOR SOLUTIONS: COMPANY OVERVIEW 232
TABLE 234 XNUO INTERNATIONAL GROUP (USA) HOLDINGS: COMPANY OVERVIEW 232
TABLE 235 OXYMED: COMPANY OVERVIEW 233
TABLE 236 KALSTEIN: COMPANY OVERVIEW 234
TABLE 237 ESS PEE ENTERPRISES: COMPANY OVERVIEW 235
LIST OF FIGURES
FIGURE 1 OXYGEN CONCENTRATORS MARKET SEGMENTATION 26
FIGURE 2 RESEARCH DESIGN 29
FIGURE 3 KEY DATA FROM SECONDARY RESEARCH 31
FIGURE 4 PRIMARY SOURCES 31
FIGURE 5 KEY DATA FROM PRIMARY SOURCES 32
FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS 33
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION 34
FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 11 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 36
FIGURE 12 SUPPLY-SIDE MARKET SIZE ESTIMATION: OXYGEN CONCENTRATORS, 2024 37
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2025–2030 38
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
FIGURE 15 TOP-DOWN APPROACH 39
FIGURE 16 DATA TRIANGULATION METHODOLOGY 41
FIGURE 17 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 18 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 45
FIGURE 19 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE,
2025 VS. 2030 (USD MILLION) 45
FIGURE 20 OXYGEN CONCENTRATORS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 46
FIGURE 21 OXYGEN CONCENTRATORS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 46
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF OXYGEN CONCENTRATORS MARKET 47
FIGURE 23 RISING INVESTMENTS IN HEALTHCARE, DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES, AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH 48
FIGURE 24 JAPAN AND PORTABLE OXYGEN CONCENTRATORS ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN ASIA PACIFIC IN 2024 49
FIGURE 25 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 50
FIGURE 26 NORTH AMERICA TO DOMINATE OXYGEN CONCENTRATORS MARKET 50
FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 51
FIGURE 28 OXYGEN CONCENTRATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58
FIGURE 30 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS,
BY REGION, 2022–2024 (USD) 60
FIGURE 31 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING
AND DISTRIBUTION PHASES 61
FIGURE 32 OXYGEN CONCENTRATORS MARKET: SUPPLY CHAIN ANALYSIS 63
FIGURE 33 OXYGEN CONCENTRATORS MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 34 OXYGEN CONCENTRATORS MARKET: INVESTMENT & FUNDING SCENARIO,
2019–2023 66
FIGURE 35 OXYGEN CONCENTRATORS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 66
FIGURE 36 OXYGEN CONCENTRATORS MARKET: NUMBER OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 (USD MILLION) 67
FIGURE 37 OXYGEN CONCENTRATORS MARKET: PATENT ANALYSIS,
JANUARY 2015−JULY 2025 70
FIGURE 38 OXYGEN CONCENTRATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 81
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS 83
FIGURE 40 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84
FIGURE 41 OXYGEN CONCENTRATORS MARKET: IMPACT OF AI/GEN AI 89
FIGURE 42 OXYGEN CONCENTRATORS MARKET: ADJACENT MARKETS 89
FIGURE 43 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET SNAPSHOT 117
FIGURE 44 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET SNAPSHOT 143
FIGURE 45 REVENUE ANALYSIS OF TOP PLAYERS IN OXYGEN CONCENTRATORS MARKET, 2020–2024 (USD MILLION) 179
FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 180
FIGURE 47 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 183
FIGURE 48 OXYGEN CONCENTRATORS MARKET: COMPANY FOOTPRINT, 2024 184
FIGURE 49 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 190
FIGURE 50 EV/EBITDA OF KEY VENDORS, 2025 193
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 193
FIGURE 52 OXYGEN CONCENTRATORS MARKET: BRAND/PRODUCT COMPARISON 194
FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 199
FIGURE 54 INOGEN, INC.: COMPANY SNAPSHOT 202
FIGURE 55 TEIJIN LIMITED: COMPANY SNAPSHOT 214
FIGURE 56 DAIKIN INDUSTRIES, LTD.: COMPANY SNAPSHOT 216
FIGURE 57 ESAB CORPORATION (GCE GROUP): COMPANY SNAPSHOT 218
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11